Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
272451-65-7
|
| gptkbp:hasMolecularFormula |
C22H25ClN2O
|
| https://www.w3.org/2000/01/rdf-schema#label |
SR144528
|
| gptkbp:is_CB2_receptor_antagonist |
true
|
| gptkbp:is_not_approved_for_medical_use |
true
|
| gptkbp:is_used_in_research |
true
|
| gptkbp:IUPACName |
N-[(1S)-endo-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-5-(4-chlorophenyl)-1-(4-methylphenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide
|
| gptkbp:molecularWeight |
368.9 g/mol
|
| gptkbp:PubChem_CID |
104865
|
| gptkbp:target |
gptkb:cannabinoid_receptor_type_2
|
| gptkbp:bfsParent |
gptkb:CB2_receptor
|
| gptkbp:bfsLayer |
7
|